Drugs / Cyclopofol
last change Dec 2024 re-read 3 minutes ago

Cyclopofol

Developed for
delirium
Investigated by
Haisco Pharmaceutical Group Co., Ltd. · RenJi Hospital

Trials 1

202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT06046638 Oct 2023 → Dec 2024 delirium, stroke disorder RenJi Hospital Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Cyclopofol ClinicalTrials.gov intervention name — accepted as the source's own label NCT06046638 ↗